Candriam S.C.A. Twist Bioscience Corp Transaction History

Candriam S.C.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$15.08 - $38.61 $542,880 - $1.39 Million	-36,000 Reduced 33.53%	71,360 $2.63 Million
Q3 2023 Nov 13, 2023	SELL	$18.62 - $26.57 $4.23 Million - $6.03 Million	-227,000 Reduced 67.89%	107,360 $2.18 Million
Q2 2023 Aug 08, 2023	BUY	$11.49 - $20.46 $287,250 - $511,500	25,000 Added 8.08%	334,360 $6.84 Million
Q1 2023 May 12, 2023	BUY	$14.6 - $30.9 $1.46 Million - $3.09 Million	100,000 Added 47.76%	309,360 $4.67 Million
Q4 2022 Feb 13, 2023	BUY	$21.92 - $39.37 $2.32 Million - $4.17 Million	106,000 Added 102.55%	209,360 $4.98 Million
Q3 2022 Nov 10, 2022	BUY	$33.44 - $56.56 $886,795 - $1.5 Million	26,519 Added 34.51%	103,360 $3.64 Million
Q1 2022 May 13, 2022	BUY	$38.58 - $83.27 $154,320 - $333,080	4,000 Added 5.49%	76,841 $3.79 Million
Q2 2021 Jul 20, 2021	BUY	$88.13 - $142.06 $6.42 Million - $10.3 Million	72,841 New	72,841 $9.71 Million

258

66.6M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.55B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.